Helen Susan Kim
CIK 1422772 · EVP, Business Development · last filed 2026-01-12
Helen Susan Kim is an EVP, Business Development who has filed 45 SEC Form 4 insider transactions across 9 companies since 2008. The most recent filing, for AKTS, was dated Jan 12, 2026. Across all open-market trades the lifetime net is −$14.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $102.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$102.53M
9
45
-$14.34M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKTS | Director | 4,859,370 | $21.10 | $102.53M | $15.03M | 1 | 2026-01-12 |
| PRTA | Director | — | $8.29 | — | $0 | 4 | 2025-05-16 |
| Applied Molecular Transport Inc. (AMTI) Delisted | Director | 575,951 | $0.26 | $151.5K | -$9.42M | 5 | 2021-08-27 |
| ASMB | Director | — | $23.23 | — | $0 | 4 | 2020-06-15 |
| XCUR | Director | — | $2.79 | — | $0 | 1 | 2020-06-08 |
| Kite Pharma, Inc. (KITE) Delisted | EVP, Business Development | 24,864 | — | — | -$19.98M | 12 | 2017-09-27 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | Director | — | $18.62 | — | $0 | 8 | 2015-07-01 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Director | — | — | — | $0 | 2 | 2013-09-24 |
| KOSAN BIOSCIENCES INC (KOSN) Delisted | President and CEO | 10,280 | — | — | $26.6K | 3 | 2008-04-02 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-12 | AKTS | Mixed | +5,829,212 | $15.03M | EDGAR |
| 2025-05-16 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2022-09-02 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2021-08-27 | Applied Molecular Transport Inc. (AMTI) Delisted | Sell (S) | −15,014 | -$453.5K | EDGAR |
| 2021-08-25 | Applied Molecular Transport Inc. (AMTI) Delisted | Sell (S) | −9,986 | -$300.3K | EDGAR |
| 2021-07-06 | Applied Molecular Transport Inc. (AMTI) Delisted | Sell (S) | −200,000 | -$8.66M | EDGAR |
| 2021-05-20 | Applied Molecular Transport Inc. (AMTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | Applied Molecular Transport Inc. (AMTI) Delisted | Exer (M) | +800,000 | $16.0K | EDGAR |